Bangladesh - English - DGDA (Directorate General of Drug Administration)

global capsules ltd., gelatin division - gelatin - raw materials - 100%

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ranvet pty. limited - gelatin - unknown - gelatin filler active 0.0 - active constituent

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - succinylated gelatin, quantity: 40 g/l - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - gelofusine is indicated as a collodial plasma volume substitute in: 1. treatment and prevention of hypovolaemia: absolute hypovolaemia from haemorrhage or other cases of intravascular fluid loss or perioperative intravascular fluid maintenance; and relative hypovolaemia secondary to induction of epidual or spinal anaesthesia, non-hypovolaemic shock. 2.hacmodilution (perioperative, therapeutic venesection). 3.extra-corporeal circulation (cardiac surgery, plasma exchange, haemodialysis).

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - succinylated gelatin, quantity: 40 g/l - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - gelofusine is indicated as a collodial plasma volume substitute in:treatment and prevention of hypovolaemia: absolute hypovolaemia from haemorrhage or other cases of intravascular fluid loss or perioperative intravascular fluid maintenance; and relative hypovolaemia secondary to induction of epidural or spinal anaesthesia, non-hypovolaemic shock. 2.haemodilution (perioperative, therapeutic venesection); 3.extra-corporeal circulation (cardiac surgery, plasma exchange, haemodialysis).

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - succinylated gelatin, quantity: 40 g/l - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - gelofusine is indicated as a colloidal plasma volume substitute in: 1. treatment and prevention of hypovolaemia: absolute hypovolaemia from haemorrhage or other cases of intravascular fluid loss or perioperative intravascular fluid maintenance; and relative hypovolaemia secondary to induction of epidural or spinal anaesthesia,non-hypovolaemic shock. 2. haemodilution (perioperative, therapeutic venesection); 3. extra-corporeal circulation (cardiac surgery, plasma exchange, haemodialysis).

Australia - English - Department of Health (Therapeutic Goods Administration)

nova pharmaceuticals australasia pty ltd - paracetamol, quantity: 500 mg - tablet, gelatin coated - excipient ingredients: sorbitol solution (70 per cent) (non-crystallising); isopropyl alcohol; titanium dioxide; gelatin; light liquid paraffin; purified water; sodium starch glycollate; magnesium stearate; pregelatinised maize starch; brilliant blue fcf; povidone; maize starch; glycerol; hypromellose; purified talc; macrogol 6000 - temporary relief of pain and discomfort associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, arthritis, osteoarthritis, rheumatic pain, period pain, fibrositis, neuralgia, sore throat, tennis elbow, and colds and flu. reduces fever.

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - ibuprofen, quantity: 200 mg - tablet, gelatin coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; hypromellose; titanium dioxide; allura red ac; microcrystalline cellulose; sodium lauryl sulfate; brilliant blue fcf; gelatin; sodium starch glycollate type a - for the temporary relief of pain (and discomfort) associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, period pain, sore throat, tennis elbow, arthritis, rheumatic pain and the aches and pains associated with colds and flu. reduces fever.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paracetamol, quantity: 498.9288 mg - tablet, gelatin coated - excipient ingredients: pregelatinised maize starch; titanium dioxide; hypromellose; allura red ac; gelatin; sodium lauryl sulfate; stearic acid; povidone - for the temporary relief of pain and fever.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paracetamol, quantity: 498.9288 mg - tablet, gelatin coated - excipient ingredients: titanium dioxide; sodium lauryl sulfate; allura red ac; gelatin; hypromellose; pregelatinised maize starch; stearic acid; povidone - temporary relief of pain associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, arthritis, osteoarthritis, rheumatic pain, period pain, fibrositis, neuralgia, sore throat, tennis elbow, and colds and flu. reduces fever.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - pomalidomide, quantity: 3 mg - capsule, hard - excipient ingredients: pregelatinised starch; sodium stearylfumarate; mannitol; croscarmellose sodium; titanium dioxide; indigo carmine; purified water; iron oxide yellow; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - pomalidomide, in combination with bortezomib and dexamethasone, is indicated for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior treatment regimen including lenalidomide.,pomalidomide, in combination with dexamethasone, is indicated for the treatment of patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.